Trial · NCT01389284
Adverse events96
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 96
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Ear pain | Ear and labyrinth disorders | Naproxen Sodium ER (BAYH6689) | 1 | 120 | 1 |
| other | Ear pain | Ear and labyrinth disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 2 | 120 | 2 |
| other | Ear pain | Ear and labyrinth disorders | Placebo | 0 | 60 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Naproxen Sodium ER (BAYH6689) | 1 | 120 | 1 |
| other | Abdominal pain | Gastrointestinal disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 1 | 120 | 1 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo | 0 | 60 | 0 |
| other | Mouth ulceration | Gastrointestinal disorders | Naproxen Sodium ER (BAYH6689) | 0 | 120 | 0 |
| other | Mouth ulceration | Gastrointestinal disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 1 | 120 | 1 |
| other | Mouth ulceration | Gastrointestinal disorders | Placebo | 0 | 60 | 0 |
| other | Nausea | Gastrointestinal disorders | Naproxen Sodium ER (BAYH6689) | 10 | 120 | 10 |
| other | Nausea | Gastrointestinal disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 9 | 120 | 9 |
| other | Nausea | Gastrointestinal disorders | Placebo | 8 | 60 | 8 |
| other | Vomiting | Gastrointestinal disorders | Naproxen Sodium ER (BAYH6689) | 4 | 120 | 4 |
| other | Vomiting | Gastrointestinal disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 3 | 120 | 3 |
| other | Vomiting | Gastrointestinal disorders | Placebo | 2 | 60 | 2 |
| other | Dental discomfort | Gastrointestinal disorders | Naproxen Sodium ER (BAYH6689) | 1 | 120 | 1 |
| other | Dental discomfort | Gastrointestinal disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 0 | 120 | 0 |
| other | Dental discomfort | Gastrointestinal disorders | Placebo | 0 | 60 | 0 |
| other | Hypoaesthesia oral | Gastrointestinal disorders | Naproxen Sodium ER (BAYH6689) | 0 | 120 | 0 |
| other | Hypoaesthesia oral | Gastrointestinal disorders | Naproxen Sodium IR (Aleve, BAYH6689) | 1 | 120 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01389284/events